MedPath

Effectiveness of the Fiocruz Vaccine ® against different variants of SARS-COV-2 in Botucatu-SP

Terminated
Conditions
COVID-19
31543
Registration Number
RBR-8yrrf9s
Lead Sponsor
niversidade Estadual Paulista Júlio de Mesquita Filho (UNESP) - Faculdade de Medicina de Botucatu (FMB)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Terminated
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Residents of Botucatu aged between 18 and 65 years. This population is estimated to be 81.472 individuals.
Residents of Polo Cuesta aged between 18-65 years.
Suspected to have SARS-CoV2 symptomatic infection and eligible as per case ascertainment guideline of the municipality for RT-PCR swab.
Informed consent prior to swabbing.
Children and adolescents (all non-vaccinated) from both communities will be included for the assessment of herd immunity. Informed consent of parents or guardians will be required.

Exclusion Criteria

Non-residents of Botucatu and healthy individuals

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath